| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/08/2002 | CA2430653A1 Transfection of human embryonic stem cells |
| 08/08/2002 | CA2428248A1 Solubility reporter gene constructs |
| 08/08/2002 | CA2426818A1 Control of gene expression in plants |
| 08/07/2002 | EP1229332A2 In vitro assay for testing gabapentinoid activity |
| 08/07/2002 | EP1229116A1 Method for preparing cell fraction containing hemangioblasts |
| 08/07/2002 | EP1229114A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 08/07/2002 | EP1229113A2 Recombinational cloning using engineered recombination sites |
| 08/07/2002 | EP1229111A2 Cultured cells of Ficus stipulata thunb. (= Ficus thunbergii) and a method for culturing tissues of the Ficus stipulata by using said cultured cells |
| 08/07/2002 | EP1229110A2 Cultured cells of Rhapiolepis umbellata Thunb. and a method for culturing tissues of the Rhapiolepis umbellata Thunb. by using said cultured cells |
| 08/07/2002 | EP1228768A1 Medicament for the protection against thrombotic diseases |
| 08/07/2002 | EP1228237A1 Expression vectors, transfection systems, and method of use thereof |
| 08/07/2002 | EP1228235A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228233A2 Methods and compositions comprising renilla gfp |
| 08/07/2002 | EP1228232A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228214A2 Erythropoietin forms with improved properties |
| 08/07/2002 | EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 08/07/2002 | EP1228206A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228202A2 Antisense compositions and cancer-treatment methods |
| 08/07/2002 | EP1228198A1 Method for modulating nitrilase selectivity, nitrilases obtained by said method and use thereof |
| 08/07/2002 | EP1228195A1 Cultures of gfap?+ nestin?+ cells that differentiate to neurons |
| 08/07/2002 | EP1228194A1 Hematopoietic differentiation of human embryonic stem cells |
| 08/07/2002 | EP1228096A1 Dog and rabbit motilin receptor orthologs |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228094A2 Congenic animal models of non-insulin dependent diabetes mellitus |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227825A1 Isolation and expansion of human marrow stromal cells |
| 08/07/2002 | EP1227824A1 Transplant/implant device and method for its production |
| 08/07/2002 | EP1227823A2 Methods for inducing (in vivo) proliferation and migration of transplanted progenitor cells in the brain |
| 08/07/2002 | EP1227822A2 Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression |
| 08/07/2002 | EP1227719A1 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 08/07/2002 | EP1181352A4 Versican and epithelial-mesenchymal interaction |
| 08/07/2002 | EP1163340A4 Compositions and methods for the modification of gene expression |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | EP0636183B1 Compositions and methods for protein structural determinations |
| 08/07/2002 | EP0618976B1 Synthetic dna sequence having enhanced insecticidal activity in maize |
| 08/07/2002 | CN1362994A Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant DNA molecules encoding these enzymes |
| 08/07/2002 | CN1362970A Monoclonal antibody against estrogen-stimulated leucine aminopeptidase |
| 08/07/2002 | CN1362969A Antimicrobial/endotoxin neutralizing polypeptide |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362965A cytoplasmic transfer to de-differentiate recipient cells |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362518A Hexulose phosphate isomerase and gene coding said isomerase |
| 08/07/2002 | CN1362514A Serumless medium suitable for growth and maintenance of young hamster kidney cell |
| 08/07/2002 | CN1362512A Aerobic cultivation method using sintering metal film |
| 08/06/2002 | US6429295 Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/06/2002 | US6429292 Glucuronide repressors and uses thereof |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/06/2002 | US6429199 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 08/06/2002 | US6429191 Treatment of hearing impairments |
| 08/06/2002 | US6429013 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 08/06/2002 | US6429012 Cell population containing non-fetal hemangioblasts and method for producing same |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6429001 Recombinant AAV packaging systems |
| 08/06/2002 | US6428990 Conversion of dihomo-gamma-linolenic acid to arachidonic acid and 20:4n-3 to eicosapentaenoic acid by host cell transformed to express human delta5-desaturase enzyme |
| 08/06/2002 | US6428989 Removing taxane producing cell clusters having a mean diameter outside the range of from 0.12 mm to 1.6 mm from the culture with a sieve or filter; culturing under agitation speed of 30-180 rpm; producing cells with high taxane yield |
| 08/06/2002 | US6428988 (aav); first cre recombinase vector, second vector contains a promoter, spacer sequence flanked by loxp sites and rep/cap, and third vector containing a transgene and regulatory sequences flanked by aav inverted terminal repeats (itr) |
| 08/06/2002 | US6428980 Involved in cell cycle regulation for use in assays screening for cell cycle modulators and use as therapeutics for controlling apoptosis, cell proliferation, etc. in disease states or for wound healing |
| 08/06/2002 | US6428978 Producing gelatin and genuine telopeptide collagen in yeasts or other cells by coexpression of dna constructs encoding alpha1(i) and alpha2(i) collagen monomers lacking the c and/or n propeptides |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428973 Immortalized human osteoclast-like cell line capable of resorbing calcified tissue in vitro; cell line using bone cells from paget's patients |
| 08/06/2002 | US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 08/06/2002 | US6428953 Retrovirus vectors; plasmids; gene delivery; genetic engineering; human immunodeficiency virus |
| 08/06/2002 | US6428802 Cellular interaction at chimeric interface producing interstitial biomaterial with morphological and functional characteristics resembling natural in vivo organ; biocompatability; genitourinary disorder; bladders |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428782 Non-myeloablative tolerogenic treatment |
| 08/06/2002 | US6428324 Vaccine |
| 08/06/2002 | CA2371042A1 Cultured cells of ficus stipulata thunb. (=ficus thunbergii) and a method for culturing tissues of the ficus stipulata thunb. by using said cultured cells |
| 08/06/2002 | CA2344954A1 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/02/2002 | CA2369477A1 In vitro assay for testing gabapentinoid activity |
| 08/01/2002 | WO2002059612A2 Animal model and cell-line expressing modified chlorine channel |
| 08/01/2002 | WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | WO2002059338A2 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059321A2 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | WO2002059318A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
| 08/01/2002 | WO2002059312A2 Cell adhesion proteins |
| 08/01/2002 | WO2002059311A2 Colon cancer marker |
| 08/01/2002 | WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059300A2 Double-stranded rna-mediated gene suppression |
| 08/01/2002 | WO2002059297A2 A library of a collection of cells |
| 08/01/2002 | WO2002059296A2 Concatemers of differentially expressed multiple genes |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059290A2 A method for evolving a cell having desired phenotype and envolved cells |